IP Library Assignment 048775/0272
Patent Assignment
Reel/Frame 048775/0272

Assignment of Assignor's Interest

Recorded: 2019-04-02 Pages: 3
Assignors
DURRANT, CAMERON
Executed: 2019-02-01
CHAPPELL, DALE
Executed: 2019-02-01
Assignee
HUMANIGEN, INC.
533 AIRPORT BOULEVARD, SUITE 400, BURLINGAME, CALIFORNIA, 94010
Covered Property (1)
Method of Reducing Tumor Relapse Rate in Immunotherapy by Administration of Lenzilumab
Application: 16/248,762 →
Publication: US 2019/0338023
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Jul 16, 2019
From: HUMANIGEN, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 049769/0067 →
Release of Security Interest Jun 12, 2020
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: HUMANIGEN, INC.
Reel/Frame 052920/0631 →